Fragasso Financial Advisors Inc cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 38.9% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,931 shares of the healthcare conglomerate's stock after selling 5,688 shares during the quarter. Fragasso Financial Advisors Inc's holdings in UnitedHealth Group were worth $4,678,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also modified their holdings of UNH. Capital & Planning LLC grew its holdings in UnitedHealth Group by 19.2% in the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate's stock valued at $248,000 after purchasing an additional 79 shares during the period. Brighton Jones LLC grew its stake in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after buying an additional 28,231 shares during the period. Union Bancaire Privee UBP SA purchased a new stake in UnitedHealth Group during the fourth quarter worth approximately $27,233,000. Revolve Wealth Partners LLC lifted its position in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after purchasing an additional 2,324 shares in the last quarter. Finally, Clear Creek Financial Management LLC lifted its position in shares of UnitedHealth Group by 2.6% during the fourth quarter. Clear Creek Financial Management LLC now owns 1,584 shares of the healthcare conglomerate's stock worth $802,000 after purchasing an additional 40 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at UnitedHealth Group
In other news, CEO Stephen J. Hemsley acquired 86,700 shares of UnitedHealth Group stock in a transaction on Friday, May 16th. The stock was bought at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the purchase, the chief executive officer now owns 679,493 shares of the company's stock, valued at $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Timothy Patrick Flynn acquired 1,533 shares of UnitedHealth Group stock in a transaction on Wednesday, May 14th. The shares were purchased at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the purchase, the director now directly owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 109,408 shares of company stock valued at $31,607,768. 0.33% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
A number of research firms have recently commented on UNH. Hsbc Global Res cut shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, May 21st. Royal Bank of Canada cut their price target on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. Morgan Stanley cut their price target on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Wolfe Research cut their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a report on Tuesday, May 20th. Finally, Wells Fargo & Company lowered their target price on shares of UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have given a buy rating to the company's stock. According to data from MarketBeat, UnitedHealth Group has an average rating of "Moderate Buy" and a consensus target price of $428.43.
View Our Latest Report on UnitedHealth Group
UnitedHealth Group Price Performance
NYSE UNH traded down $0.30 on Thursday, reaching $300.08. The company's stock had a trading volume of 4,697,841 shares, compared to its average volume of 6,902,745. The firm's 50 day moving average is $418.00 and its two-hundred day moving average is $488.12. The stock has a market cap of $272.21 billion, a PE ratio of 19.36, a PEG ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the prior year, the firm earned $6.91 EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.